DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
DarioHealth Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$4.49−0.33 (-6.85%)
Close on Oct 19, 2026
- Market cap
- $41.95M
- P/E (TTM)
- 1.1
- Dividend yield
- –
DarioHealth Corp. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Services | $11.80M | $12.88M | $14.93M | $17.52M | $19.91M | $20.91M | $20.20M | $16.34M | $12.50M | $11.99M | $13.08M | $16.23M | 56.2% | -40.7% |
| Consumer hardware | $9.20M | $8.31M | $7.43M | $7.21M | $7.24M | $7.12M | $6.84M | $6.72M | $6.65M | $7.06M | $7.27M | $7.32M | 43.8% | +27.1% |
| Agreement with National Health Plan | – | – | – | – | – | – | – | – | – | – | $962.00K | $962.00K | – | – |
| Development Services Per Exclusive Agreement Year Two [Member] | – | – | – | – | – | – | – | – | – | – | $2.49M | – | – | – |
| Development Services Per Exclusive Agreement Year Three [Member] | – | – | – | – | – | – | – | – | – | $2.59M | $2.10M | – | – | – |
By region
From the segment and revenue-disaggregation notes of DarioHealth's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.